The last few decades have seen a marked increase in mean life expectancy in Central Europe. This has made elderly people and their quality of life a matter of ever-increasing medical concern. Available data from the United States and Scandinavia relating to erectile dysfunction (ED) do not enable us to draw valid conclusions about the current situation in Germany. The aim of the present study was to evaluate the epidemiology of male sexuality in Germany, and the proportion of men who need medical treatment because of increased suffering from this.
Introduction
Erectile dysfunction (ED) is de®ned as the inability to attain andaor maintain penile erection suf®cient for satisfactory sexual performance. 1 In Central Europe, and speci®cally in Germany with its 80 million inhabitants, the prevalence of ED is unknown. 2 The introduction of Sildena®l in Germany, changed the therapeutic options for masculine sexual disorders and led to a change in the numbers of patients seeking medical help. 3 Meanwhile there has been a lot of research focusing on graduated diagnosis and treatment options. 4±7 There are only a small number of epidemiological investigations with differential results. Sexuality underlies socio economic and cultural¯uctuations, and it is not surprising, that studies which have been carried out at different times and in various cultures, produce differential results. 8±12 Study populations are frequently small in number and biased towards a certain characteristic, eg smokers. 13, 14 The aim of the present study was to analyse the epidemiology of sexual activity, ED and its co-morbidities as well as treatment demands from ED in a age-strati®ed population sample of German men.
Materials and methods
An age-strati®ed population, re¯ecting German male age structure between 30 and 80 y of age, of 8000 men in the Cologne district was approached by letter with a recently developed and validated questionnaire for male ED (the`Ko È lner Erfassungsbogen der Erektilen Dysfunktion' [Cologne ED Questionnaire], KEED). 15 The questionnaire was sent by post and non-responders were twice requested (by mail) to complete the questionnaire. After a description of the study had been given and data protection regulations were guaranteed, the subjects' addresses were provided by the Cologne Municipal Registry of Inhabitants. To obtain a population based cohort, several criteria were selected. The primary distinction was the men's age, and secondly the marital status was considered. The`Cologne-area' contains an urban portion as well as rural areas. By selecting men from both areas, the German cityacountry (6900a1100 87% urban to 13% rural inhabitants) distribution was matched (information from the Federal Government).
The questionnaire consisted of four parts: ®rst, a cover-sheet with demographic and socio-economic data; second, the set of questions on sexuality (KEED); third, data on micturation;`lower urinary tract symptoms' (LUTS); and fourth, the treatment preference was ranked (drugs, erection devices, self injection therapy, vascular surgery, prosthesis implants).
KEED
The KEED is an 18-item questionnaire for the evaluation of ED, developed and validated in Germany that is aimed to identify symptoms of ED and its effects on quality of life. Questions 1±8 assess sociodemographic characteristics, medical history, and medication, smoking and alcohol consumption habits. Questions 9 and 10 assess for sexual desire and frequency of sexual activities. Questions 11±16 assess erectile and orgasmic function on a 5-point Likert scale, allowing calculation of an`ED-score'. Men were scored as impotent, when they reached more than 17 points on the EDrating scale. Satisfaction with sex life and general well-being are covered by the last two questions. In this point of view, men were dissatis®ed with the current sex life, if they answered with`mixed' or worse (Appendix 1).
LUTS
Lower urinary tract symptoms (LUTS) were assessed by using IPSS-questions (International prostate symptom score) without any scale rate. Presence of LUTS was de®ned by a positive response to at least two IPSS items (Appendix 2).
Statistical methods
Crude prevalences, means and 95% con®dence intervals (CIs) were calculated for each age group separately. For prevalences, exact Clopper-Pearson CIs were calculated for taking into account low prevalence rates. Multiple logistic regression analysis was performed to estimate the odds ratios of ED in relation to potential risk factors and age. The calculations were performed using the Statistical Analysis System SAS 6.12.
Results
A total of 4883 men replied (61.0% response rate), with 4489 questionnaires (56.1%) completed and evaluable. The response rates for different age groups ranged between 49.2% and 68.4% ( Table  1 ). The responders' mean age was 51.8 y. Two-thirds (66.1%) of the men were married or lived in a stable relationship with a partner, 21.1% were single, 9.2% divorced, and 3.5% widowed ( Table 1) . Overall, the men had a mean of 2.2 family members. The mean family income (without tax rates) was 3750 DM (appr. 1900 Euro) per month ( Table 1) . These results are comparable with the German socioeconomic data. There was only a slight difference between the response rate of the rural area and the urban area. In Germany, 87% of the inhabitants are living in urban areas; in contrast only 9.3% (427 men) of our respondents live in rural areas.
Ninety-six per cent (youngest age group) to 71.3% (oldest group) reported regular sexual activity, including auto-erotic activity and exchange of caresses without sexual intercourse. Although frequency of sexual activity decreased with age, 66.1% of men aged 60±69 and 41.5% of those aged 70±80 y reported at least weekly sexual activity. There were 11.1±19.4% of responders who were dissatis®ed with their current sex life, with the highest prevalence for men aged 60±69 ( Table 1) .
The prevalence of ED was 19.2%, with a steep age-related increase (2.3±53.4%) ( Table 1 ). The increase was linear in the age-groups from 30 to 59 y, while the age-groups from 60 upwards showed an exponential increase in prevalence. When treatment need was de®ned by co-occurrence of ED and dissatisfaction with sex life, 6.9% of men required urological treatment for ED. The proportion of men requiring such treatment for ED was highest in the age group 60±69 (14.3%, Table 1 ).
The`Massachusetts Aging Male Study' identi®ed hypertension, diabetes mellitus and pelvic surgery as associates of erectile disorders. Our study replicated the signi®cant co-morbidity of ED with these disorders. Additionally we found a 72.2% prevalence of`lower urinary tract symptoms' (LUTS) in patients with ED as compared with a 37.7% prevalence of LUTS in non-ED patients (Table 2) . Drinking alcohol and smoking was not signi®cantly more often found in the group of men with ED. The age-adjusted odds ratios are presented in Table 3 .
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These range from 1.58 (hypertension) to 6.03 (pelvic surgery) and are in accordance to previous ®ndings. Compared with the youngest age group the oldest age group has a 22-fold higher risk for ED. The risk for the 40±49 age group is still nearly 4-fold higher (Table 3) .
Oral treatment was indicated to be preferred by 73.8% of the respondents (Figure 1 ). In the total sample 46.2% of respondents were willing to contribute more than DM 50 (25 Euro) monthly, 8.1% were even ready to pay any amount. The burden, associated with ED, is re¯ected in the Table 4 ). In ED sufferers willingness to pay was not signi®cantly correlated with household income.
Discussion
The great advances in diagnosis and basic research on ED over the last 10 years have provided an exemplary demonstration, of the need for Epidemiology of erectile dysfunction M Braun et al interdisciplinary, sex-speci®c research. At the same time there has been a radical change from the view that this disorder was almost exclusively psychogenic, to an acceptance of a predominantly organic, multifactorial aetiology. 17 Until 20 years ago, in the absence of appropriate morphological diagnostic techniques, the diagnosis and treatment of ED was provided by psychologically and psychosomatically oriented physicians. The development of intracavernosous injections to induce erections led to the acceptance of organically caused erectile disorders. 16, 17 Over the past 20 years, therefore, a new ®eld of activity has been opened up for the urologist. The degree of expression of sexual disorders is subject to social and cultural variation, and it is all the more surprising that the Kinsey Report, published as early as 1948, for many years represented the only source of reliable data on the subject. 7 In that study, the prevalence of ED rose from less than 1% among men aged under 30 years to over 75% in 80-year-old men. The wide variance in prevalence data can be clearly seen by looking at the studies carried out in Scandinavia and the Netherlands. Diemont, for example, questioned 331 men aged 20± 65 y and reported an ED rate of 2.7%. 11 Lendorf et al came to a similar conclusion, reporting an ED rate of 4% in 272 men with ages ranging from 30 to 79 y. The ED rate of men aged 60 upwards in this study, however, differed markedly from that found by Kinsey, with a ®gure of 10±11% as compared to 25±75%. 8 The study published by Feldmann et al referred to at the beginning of this report showed an overall prevalence of 20% for complete ED, while a signi®cantly higher proportion of men suffered from mild to moderate degrees of disturbance of sexual function. Also the correlation with concomitant diseases and medication was calculated. Thus, it was shown that patients with cardiac disease, diabetes mellitus or hypertension had a higher prevalence of symptoms of ED than the total sample. There was a correspondingly above-average prevalence among men treated with vasodilators, cardiac drugs, antihyperglycaemic and antihypertensive agents. 9 These data were supported by a survey in France, which also reported an overall prevalence rate of 20% amongst men aged from 18 to 69 y. 12 If we apply these data to the population of the German Federal Republic, we would have to reckon on some 6±8 million men (approximately 20% of the total German male population) suffering from erectile disorders.
Our data agree with these studies in showing a similar prevalence of erectile disorders. We also identi®ed the classical diseases and treatments in our population Ð arterial occlusive disease, diabetes mellitus and pelvic surgery. However, a new element was the pronounced and statistically highly signi®cant relationship between ED and LUTS. Although there is as yet no pathogenetic explanation to account for this, further scienti®c research on this concurrence of two major urological symptoms appears to be urgently required.
A crucial assumption of our study is that the results are not affected by the selection of responders from the target population. In order to detect a possible response bias, we compared the basic characteristics (ie family status, family members, and family income) of the study participants with those from the target population. The response rate did not show an age-speci®c shape. In addition, we compared the ®ndings of our study between subjects responding quickly and those responding after reminders. None of these ®ndings suggest that our results were affected or produced by response bias.
A major aspect of our study, as compared with those cited above, is the differentiation made between men with ED and those who suffer speci®c distress because of this condition. If we take impairment of erectile function and the presence of distress caused by it as the indication for symptomatic treatment, then the importance of diagnostic tools and algorithms for the correct identi®cation of men with sexual dysfunction becomes apparent. It has been possible, with the help of KEED (`Ko È lner Erfassungsbogen der Erektilen Dysfunktion'), to identify those men who had erectile impairment and at the same time, were distressed by it. 15 Thus we were able to show that approximately 19% of respondents reported demonstrable erectile impairment, while only 6.8% required urological treatment. Shabisigh and Solstad made the same ®ndings, in smaller studies. 18, 19 The new era of development in medico-pharmacological technology is making it increasingly possible to intervene therapeutically in degenerative ageing processes which used previously to be taken for granted. The pharmaceutical industry has adjusted to this need, and coined the very appropriate concept of`lifestyle drugs'. Our questionnaire thus showed that a high percentage of the male population is prepared to pay out signi®cant sums of money every month (about 50±100 DM, 25±50 C ) in order to obtain drug treatment for potency disorders with an effective`potency drug'; the slight correlation with family income is no surprise.
Although the importance of quality of life in the elderly is rated very highly, the Ð at least partial Ð identi®cation of sexuality with quality of life in old age is readily made a taboo subject. At the same time, the protective effects of sexual ful®lment on general health, even in the elderly, cannot be denied, and approximately 60% of men aged over 65 possess sexual desire (libido). In spite of this, many people have a sceptical attitude towards the maintenance of physical sexual function, which is required in both men and women for sexual intercourse. 20 The creation of a taboo in this context is partly a consequence of the way the older generations were brought up, and is further promoted by the lack of attention paid to ED by even the Epidemiology of erectile dysfunction M Braun et al medical profession. It will be necessary in future to investigate similar questions in women, so as ultimately to make it possible to draw some conclusions to guide health policy in relation to the quality of life of our older fellow-citizens, with particular reference to their sexuality. 13 
